Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 21-30 of 68

Page
per page
  1. CGK733
    A8624 CGK733
    Target: ATM/ATR
    Summary: ATM/ATR inhibitor,potent and selective
      ≥27.8 mg/mL
  2. Capecitabine
    A8647 Capecitabine
    Summary: DNA, RNA and protein synthesis inhibitor
      ≥10.97 mg/mL
  3. Oxaliplatin
    A8648 Oxaliplatin
     3 Citation
    Summary: Antitumor agent
      insoluble in EtOH; ≥37.25 mg/mL
  4. RGFP966
    A8803 RGFP966
     4 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: Specific HDAC3 inhibitor
      insoluble in H2O; ≥18.12 mg/mL
  5. Triapine
    B3209 Triapine
    Target: Ribonucleotide Reductases
    Summary: Ribonucleotide reductase inhibitor
      ≥83.33 mg/mL
  6. VE-822
    B1383 VE-822
     2 Citation
    Target: ATM/ATR
    Summary: ATR inhibitor
      ≥50 mg/mL
  7. Beta-Lapachone
    B2290 Beta-Lapachone
    Target: Topoisomerases
    Summary: DNA topoisomerase I inhibitor,selective
      insoluble in H2O; ≥10.85 mg/mL
  8. Lomustine
    B1963 Lomustine
     1 Citation
    Target: RNA synthesis
    Summary: Antineoplastic drug
      insoluble in H2O; ≥23.41 mg/mL
  9. Daun02
    A3352 Daun02
     2 Citation
    Summary: Cell viability inhibitor,DNA synthisis inhibitor
      insoluble in H2O; insoluble in EtOH; ≥17.92 mg/mL
  10. Irinotecan HCl Trihydrate
    B2293 Irinotecan HCl Trihydrate
    Target: Topoisomerases
    Summary: Topoisomerase 1 inhibitor
      ≥23.1 mg/mL

Items 21-30 of 68

Page
per page